Ascendis Pharma AS (ASND)
136.24
-1.50
(-1.09%)
USD |
NASDAQ |
Dec 20, 16:00
136.20
-0.04
(-0.03%)
After-Hours: 20:00
Ascendis Pharma Market Cap: 8.142B for Dec. 20, 2024
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Novo Nordisk AS | 377.51B |
| Evaxion Biotech AS | 5.391M |
| Trinity Biotech PLC | 22.02M |
| Akari Therapeutics PLC | 24.02M |
| Biodexa Pharmaceuticals PLC | 2.265M |
Market Cap Related Metrics
| PS Ratio | 21.92 |
| Price | 136.24 |
| Earnings Yield | -5.95% |